Researchers at the University of Connecticut have identified the presence of prestin, an inner-ear protein, in the blood of patients suffering from tinnitus.
Published in August 2026 in Otolaryngology-Head and Neck Surgery, this discovery marks a potential step toward developing an objective blood test for a condition that currently relies entirely on patient self-reporting.
Dr. Patrick Adamczyk and Dr. Kourosh Parham conducted the study by analyzing blood samples from 82 adults, half of whom had experienced tinnitus in both ears for several months. The team measured four proteins—prestin, otoferlin, connexin 26, and stereocilin—to determine if any could serve as a biological marker for the condition.
The results showed that serum levels of prestin were significantly higher in the tinnitus group, with an average increase of approximately 330 picogrammes per milliliter, or about 50% higher than in the control group. This gap remained statistically significant even after adjusting for age, noise exposure, and existing hearing loss.
Despite the correlation, the researchers found that prestin levels cannot yet function as a definitive diagnostic tool. No specific threshold of the protein reliably distinguished patients with tinnitus from those without.
The study authors said that because some cases of tinnitus originate in the brain rather than the cochlea, a cochlear-based marker like prestin would not detect those instances.
The study did not find a direct relationship between the concentration of prestin in the blood and the reported severity of a patient's symptoms. Because the protein is also present in other tissues, such as the heart, its exact origin in the bloodstream remains under investigation.
The current findings serve as a proof of concept rather than a clinical diagnostic test. Because the study focused on a limited sample size, the researchers emphasize the need for larger cohorts to validate these results.
Future studies are expected to include patients with recent or particularly severe cases of tinnitus, which were not represented in the initial group.
No commercial laboratory offers this blood test for clinical use, as the methodology remains confined to research protocols.
Is there a standard blood test for tinnitus?
No. Currently, there are no laboratory tests to diagnose tinnitus. Physicians rely on the patient’s description of their symptoms to evaluate the condition.
Why does prestin end up in the blood?
Prestin helps regulate the vibration of outer hair cells in the cochlea, which amplify quiet sounds. Researchers hypothesize that when these cells are damaged, the protein may leak from the inner ear into the bloodstream.
Can this test be used at a doctor’s office today?
No. The research is in its early stages and is not yet available for general medical practice. Additional studies are required to confirm the reliability of the marker across larger populations.
Related reading